AI in oncology

“Tax planning was one major reason for the foundation of Elekta.” Larry Leksell says it with a smile that suggests he enjoys disrupting the mythology people create around founders. Most people expect a grand story of origin. A visionary revelation.…

In oncology, we are trained to deliver hope alongside difficult truths. We speak about survival rates, probabilities, and outcomes. In conflict settings, those terms lose stability. What does survival mean when hospitals are destroyed, treatments cannot reach patients, and people…

Sixteen years ago, Dr. Michael Gnant was portrayed in CancerWorld as a surgical oncologist unafraid to push boundaries in breast cancer care. Today, his perspective reflects not retreat but evolution. The boundary-pusher remains, but his focus has widened. His work…

Imagine an oncologist stepping out of tumor board and into clinic with a complex case at hand. The patient’s tumor has multiple high-risk features, genomic mutations, and borderline indications for therapy. In the past, the doctor might sift through guidelines,…

Where leadership, legacy, and discovery meet the future of care Every issue of CancerWorld tells a story about connection, between science and humanity, between personal courage and collective change. The November edition celebrates those who lead with conviction, those who…